Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001949292 | SCV002246431 | pathogenic | Autoimmune lymphoproliferative syndrome type 1 | 2024-01-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp176*) in the FAS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAS are known to be pathogenic (PMID: 10875918, 22237435). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with autoimmune lymphoproliferative syndrome (PMID: 22237435). ClinVar contains an entry for this variant (Variation ID: 1457614). For these reasons, this variant has been classified as Pathogenic. |
Prevention |
RCV003401971 | SCV004121506 | pathogenic | FAS-related disorder | 2022-09-07 | criteria provided, single submitter | clinical testing | The FAS c.528G>A variant is predicted to result in premature protein termination (p.Trp176*). This variant was reported in an individual with autoimmune lymphoproliferative syndrome (Hsu et al. 2011 Table 1 PubMed ID: 22237435). In vitro functional studies show that this variant results in reduced expression of a truncated protein that did not anchor on the cell surface (Kuehn et al. 2011 PubMed ID: 21490157). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in FAS are expected to be pathogenic. This variant is interpreted as pathogenic. |